Huntington National Bank »

Theravance Biopharma shares owned by Huntington National Bank

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $788 88 8.97

More positions owned by Huntington National Bank

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Jp Morgan Chase & Co Common Stock (JPM)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IJR)
Eli Lilly & Co Common Stock (LLY)
SPDR Exchange Traded (Principal) (SPTM)
Ishares Exchange Traded (Principal) (IJH)
Alphabet Common Stock (GOOGL)
Ishares Exchange Traded (Principal) (IVW)
Amazon.com Common Stock (AMZN)
Ishares Exchange Traded (Principal) (IVE)
Exxon Mobil Corp Common Stock (XOM)
Visa Common Stock (V)

View all positions for Huntington National Bank

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
BlackRock
Irenic Capital Management
Vanguard Group
Pictet Asset Management Holding SA
Newtyn Management
Oasis Management
Park West Asset Management
Geode Capital Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Bank of America Corporation
Northern Trust
Morgan Stanley

View all funds holding Theravance Biopharma